Beijing Wantai’s HIV Urine Self-Test Kit Gains WHO Prequalification

Fineline Cube
1 Min Read
Summarize with AI

China-based Beijing Wantai Biological Pharmacy Enterprise Co., Ltd (SHA: 603392) announced that its HIV urine self-test kit—human immunodeficiency virus type 1 urine antibody test kit (colloidal gold method)—has obtained Prequalification (PQ) status from the World Health Organization (WHO) and has been included in the agency’s in vitro diagnostic (IVD) products list.

- Advertisement -

Product Overview
This product follows in the footsteps of Wantai Bio’s human immunodeficiency virus antibody diagnostic kit (enzyme-linked immunoassay) and human immunodeficiency virus (HIV 1+2) antibody detection kit (colloidal gold method), both of which have previously won WHO PQs. The HIV urine self-test kit is the world’s first of its kind to achieve this status, marking a significant milestone in the global fight against HIV/AIDS.-Fineline Info & Tech

Share This Article